Dahan Michel

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
20
Insider Sells Sum
$947,699.20

Insider Activity of Dahan Michel

According to the SEC Form 4 filings, Dahan Michel, being in a position of

  1. SVP, Chief Operating Officer at Akebia Therapeutics, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 34840 shares for $43,898,
    over all time since 2016-04-04, has bought 0 shares, and sold 264550 shares for $947,699.

The largest sale of all time was on 2017-09-28 and amounted to 10000 shares of Akebia Therapeutics, Inc. for $193,000.

Biography of Dahan Michel

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Prismo
Buys
 $000
Sells
 $43,8981100

Comparison of Insiders on Amount of Buys and Sells

Prismo
Prismo
2024-05-13SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
34,840
0.0162%
$1.26$43,898+15.5%
2024-02-29SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
8,661
0.0046%
$1.58$13,684-7.28%
2024-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
10,744
0.0053%
$1.52$16,331-10.37%
2023-05-25SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
95,478
0.0522%
$1.22$116,760+3.31%
2023-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
20,412
0.0107%
$0.88$17,912+23.5%
2023-02-27SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
10,090
0.0055%
$0.81$8,205+38.48%
2022-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
14,978
0.0084%
$2.17$32,513-80.93%
2022-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
6,555
0.0036%
$2.15$14,125-81.02%
2021-04-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
1,211
0.0008%
$3.40$4,117-15.92%
2021-03-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
14,547
0.0095%
$3.40$49,403-14.84%
2020-02-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Operating Officer
6,972
0.0053%
$8.70$60,656-34.16%
2017-10-02SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,796
0.0058%
$19.64$54,913-45.25%
2017-09-28SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
10,000
0.0214%
$19.30$193,000-43.7%
2017-08-15SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
10,000
0.0211%
$15.00$150,000-4.78%
2017-07-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,798
0.0058%
$14.26$39,893-0.51%
2017-04-03SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,802
0.007%
$9.18$25,715+64.77%
2017-01-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
3,258
0.0087%
$10.49$34,178+33.14%
2016-10-01SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,802
0.0074%
$8.95$25,091+14.17%
2016-07-05SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,804
0.0074%
$7.47$20,936+21.67%
2016-04-04SaleAkebia Therapeutics, Inc.
AKBA
SVP, Chief Business Officer
2,802
0.0073%
$9.41$26,367-7.02%
Total: 20
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Sells over the last 12 months, USD